https://www.egetis.com/news/year-end-report-january-december-2025/
Year-End Report January-December 2025 - Egetis Therapeutics
Sep 29, 2026 - Egetis submitted the U.S. NDA for Emcitate® (tiratricol) for treatment of MCT8 deficiency · Emcitate® revenue during 2025 amounted to MSEK 62.3, a 40 %...
year end reportjanuarydecemberegetistherapeutics
https://www.egetis.com/news/change-in-the-number-of-shares-and-votes-in-egetis-therapeutics-3/
Change in the number of shares and votes in Egetis Therapeutics - Egetis Therapeutics
Sep 29, 2026 - Stockholm, Sweden, October 31, 2023. The number of shares and votes in Egetis Therapeutics AB (publ) (“Egetis” or the “Company”) (STO: EGTX) has increased in...
in thenumber ofchangesharesvotes
https://www.egetis.com/news/egetis-nomination-committee-for-the-2024-annual-general-meeting/
Egetis’ Nomination Committee for the 2024 Annual General Meeting - Egetis Therapeutics
Sep 29, 2026 - Stockholm, Sweden, November 1, 2023. Egetis Therapeutics AB (publ) (NASDAQ Stockholm: EGTX) today announced the composition of the Nomination Committee for the...
annual general meetingnomination committeefor theegetistherapeutics
https://www.egetis.com/news/egetis-therapeutics-to-host-meetings-in-san-francisco-during-j-p-morgan-healthcare-conference-week/
Egetis Therapeutics to Host Meetings in San Francisco During J.P. Morgan Healthcare Conference Week...
Sep 29, 2026 - Stockholm, Sweden, January 8, 2026. Egetis Therapeutics AB (publ) (“Egetis” or the “Company”) (NASDAQ Stockholm: EGTX), a commercial-stage orphan drug company,...
in san franciscoj p morganegetistherapeuticshost
https://www.egetis.com/news/pledpharma-presenterar-lakemedelskandidaten-pledox-globala-fas-iii-program-pa-asco/
PledPharma presenterar läkemedelskandidaten PledOx® globala fas III program på ASCO - Egetis...
Sep 29, 2026 - PledPharma AB (publ) meddelar att bolagets globala fas III-program för PledOx®, POLAR, kommer att presenteras på en poster session på onkologikonferensen ASCOs...
presenterarglobalafasiiiprogram
https://www.egetis.com/sv/nyheter/pressmeddelanden/
Pressmeddelanden - Egetis Therapeutics
Aug 10, 2026 - Sök efter våra senaste pressmeddelanden och bolagsrapporter
pressmeddelandenegetistherapeutics
https://www.egetis.com/news/bulletin-from-egetis-therapeutics-annual-general-meeting-2022/
Bulletin from Egetis Therapeutics’ Annual General Meeting 2022 - Egetis Therapeutics
Sep 29, 2026 - Stockholm, Sweden, May 30, 2022. Egetis Therapeutics AB (publ) (STO: EGTX) today announced that the Annual General Meeting (AGM) has been held on May 30, 2022,...
annual general meetingbulletinegetistherapeutics
https://www.egetis.com/news/aktier-for-ytterligare-10-mkr-placerade/
Aktier för ytterligare 10 Mkr placerade - Egetis Therapeutics
Sep 29, 2026 - PledPharma AB Pressmeddelande Aktier för ytterligare 10 Mkr placerade Stockholm, 2011-05-24 11:32 CEST (GLOBE NEWSWIRE) -- Ytterligare teckningsförbindelser...
aktierytterligaremkrplaceradeegetis